Anti-Cancer Drug Development in Japan

일본의 항암제 개발 동향

  • Kim, Sam-Yong (Department of Internal Medicine, College of Medicine, Cancer Research Institute, Chungnam University)
  • 김삼용 (충남대학교 의과대학 내과학교실, 암공동연구소)
  • Published : 1994.12.31

Abstract

This survey is a sketchy description on anticancer drug development in Japan mainly focusing on preclinical development and phase I clinical trials. Anticancer drug hunting in Japan is mainly pursued in pharmaceutical companies and the results are quite impressive. Several companies in Japan have keen successful in developing many kinds of DNA-reacting anti-cancer agents like Mitomycin-C and it's derivatives.

Keywords